1 / 2

Biosurgery Market by Product, Application Forecast to 2021

The report “Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitues) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2021", analyzes and studies the global biosurgery market during the forecast period of 2016 to 2021. The global biosurgery products market is expected to grow at a CAGR of 8.8% during the forecast period, to reach USD 27.78 Billion by 2021.

Download Presentation

Biosurgery Market by Product, Application Forecast to 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Biosurgery Market by Product Application Forecast to 2021 The report “Biosurgery Marketby Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitues) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2021", analyzes and studies the global biosurgery market during the forecast period of 2016 to 2021. The global biosurgery products market is expected to grow at a CAGR of 8.8% during the forecast period, to reach USD 27.78 Billion by 2021. Browse 315 market data tables and 44 figures spread through 264 pages and in-depth TOC on “Biosurgery Market” http://www.marketsandmarkets.com/Market-Reports/biosurgery-market-166922302.html Early buyers will receive 10% customization on this report. Industry Insights: In this report, the biosurgery market is segmented on the basis of product type, application, and geography. The product segment is segmented into surgical sealants, hemostatic agents, adhesion barriers, bone graft substitutes, and staple line reinforcement agents. The bone graft substitutes market is further sub-segmented into bone-allografts, demineralized bone matrix, bone morphogenetic proteins, and synthetic bone-grafts. The soft tissue attachments segment accounted for the largest share of the global biosurgery products market in 2015. This is majorly attributed to the rampant use of soft tissue patches across different types of surgeries. This segment will further continue to dominate the biosurgery products market by 2021, majorly due to the rising demand of these products from emerging countries and widening applications of soft tissue repair products across surgical procedures. Get The PDF Brochure For This Report: http://www.marketsandmarkets.com/pdfdownload.asp?id=166922302 Geographical Scenario: On the basis of region, the biosurgery market is broadly segmented into North America, Europe, Asia- Pacific, Latin America, and Middle East and Africa. Presence of large number of market players, well- developed healthcare system, and presence of large number of hospitals in North America have boosted the growth of the biosurgery market in this region. However, Asia-Pacific region is expected to grow at the highest CAGR, owing to rising health awareness, growth in per capita income, and improving healthcare infrastructure in this region. Request a sample of the report: http://www.marketsandmarkets.com/requestsample.asp?id=166922302

  2. Industry Leaders: The major players operating in this market include Baxter International Inc. (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc. (Ireland), Getinge Group (Sweden), B. Braun Melsungen AG (Germany), Cryolife Inc. (U.S.), Stryker Corporation (U.S.), Hemostasis, LLC. (U.S.), and Sanofi Group (France). New product launches and acquisitions are the key strategy adopted by players in the biosurgery market. About MarketsandMarkets™: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States E-mail: sales@marketsandmarkets.com Tel: 1-888-600-6441

More Related